Online Pharma Indexes - Databases and Directories of Pharma Companies

Pharma Indexes are databases or simply lists of pharmaceutical companies and increasingly they are found online, raising some questions perhaps for companies whose operations mean they automatically they must have pharmacovigilance services for their products. The directories are typically categorised by things like different states, such as EU member states for example, or by different aspects of the pharmaceutical industry. Their data organisation is commonly hinged around the type of results which lend themselves to search results. Broadly speaking, a Pharma list is likely to be a fairly comprehensive directory of pharmaceutical operations.

Pharma Indexes typically use alphabetical ordering and contain information such as company details, their site links, address and other contact information. There are directories which constitute a globe wide catalogue of pharmaceutical companies and then again, there are those that feature information on particular countries. The Net platform is actually now a highly useful resource for all-inclusive databases or business directories for pharmaceuticals product manufacture, production and distribution companies. As well as Pharma indexes, pharmaceutical firms have also been occupying web space in a radically new way of late.

It was fairly recently that two giants within the industry, Nova Nordisk and Pfizer began their own pages on the social media networking site, Twitter. It looks to the outside observer that the pages are intended to get the word out there about new drug treatments, fresh products and developments, and perhaps strengthening relationships with their customer bases. Historically, pharmaceutical firms had not so readily embraced new media such as social networking sites or blogs. The difficulty in tracking the monetary gains from doing so could be one factor holding back the stampede. Another could be simply the nature of the industry - all firms producing pharmaceutical products must routinely provide or outsource suitable pharmacovigilance services as part of their work, in order to market their products in accordance with the many pharmacovigilance regulations. Perhaps it was the case that time was needed to develop a good fit between those regulatory requirements and productively using those newer media. With companies now beginning to explore this brave new world though, some choose external firms to produce an online presence for them, whilst not being actively engaged in the matter directly.

The web platform is such a good host for those comprehensive databases or business directories in that there are some end-user benefits to be had. Consumers can now simply browse through pharmaceutical product catalogues online, placed into cyberspace by producers within the Pharma industry. Its common for catalogues like this to list names and details of exporters, importers and wholesalers.

On the other hand, the industry's key customers are of course the bulk buyers - drug store owners, labs and sales delegates. Indeed, many directories actively promote the idea of only enrolling companies selling at market costs.

All that web activity does raise some concerns for pharmaceutical companies though, in that their online presence in the newer media needs to be carefully managed from a regulatory minded standpoint, at the very least. Details of adverse serious events which somehow reached something like Twitter should of course instead be subject (by law) to expedited reporting. If the new media somehow caused the company to miss an expedited reporting deadline that would of course be highly undesirable. For this and any other hypothetical concerns though, working closely with senior consultants from pharmacovigilance services should enable companies to know where they stand in regards to regulatory matters.